Repligen (RGEN) EBIT Growth (1y) (2011 - 2026)
Repligen (RGEN) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 30.74% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -75.72% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -26.09% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 17.25% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 16.53% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -116.77% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -46.71% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 8.28% |
| 10 | Repligen | 7.75 Bn | 6.77 Bn | 108.28 Mn | 142.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 142.32% |
| Dec 31, 2025 | 148.95% |
| Sep 30, 2025 | 314.82% |
| Jun 30, 2025 | 154.09% |
| Mar 31, 2025 | 75.41% |
| Dec 31, 2024 | -469.71% |
| Sep 30, 2024 | -266.96% |
| Jun 30, 2024 | -71.64% |
| Mar 31, 2024 | -72.94% |
| Dec 31, 2023 | -79.78% |
| Sep 30, 2023 | -91.09% |
| Jun 30, 2023 | -69.48% |
| Mar 31, 2023 | -76.90% |
| Dec 31, 2022 | 30.47% |
| Sep 30, 2022 | 16.53% |
| Jun 30, 2022 | 30.95% |
| Mar 31, 2022 | 64.91% |
| Dec 31, 2021 | 114.89% |
| Sep 30, 2021 | 115.61% |
| Jun 30, 2021 | 146.92% |